Get started
Author

Jonas Felix Busch

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2022 · Thomas Powles, Piotr Tomczak, et al. · The Lancet Oncology · 320
PDF
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
2012 · J. Beyer, P. Albers, et al. · Annals of Oncology · 318
PDF
Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients
2020 · Annika Fendler, Daniel Bauer, et al. · Nature Communications · 198
PDF
Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury
2022 · Christian Hinze, Christine Kocks, et al. · Genome Medicine · 137
PDF
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial
2022 · Maciej Jacewicz, Karsten Günzel, et al. · The Lancet Infectious Diseases · 120
Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas
2015 · Jonas Busch, Bernhard Ralla, et al. · Journal of Experimental & Clinical Cancer Research · 117
PDF
Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors
2010 · Annika Schaefer, Carsten Stephan, et al. · Nature Reviews Urology · 115
Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role
2017 · Sophia Spatz, Yuri Tolkach, et al. · The Journal of Urology · 112
Residual Tumor Size and IGCCCG Risk Classification Predict Additional Vascular Procedures in Patients with Germ Cell Tumors and Residual Tumor Resection: A Multicenter Analysis of the German Testicular Cancer Study Group
2011 · Christian Winter, David Pfister, et al. · European Urology · 100
Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma
2016 · Julia Liep, Ergin Kilic, et al. · PLoS ONE · 97
PDF
Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas
2012 · Zofia Wotschofsky, Julia Liep, et al. · International Journal of Biological Sciences · 89
PDF
Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases
2011 · Zofia Wotschofsky, Helmuth-Alexander Meyer, et al. · Analytical Biochemistry · 88
Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI
2018 · Lisa C. Adams, Bernhard Ralla, et al. · Cancer Imaging · 85
PDF
Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes
2019 · Federico Collettini, Judith Enders, et al. · Radiology · 79
Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta
2012 · Mauricio M. Sendeski, Anja Bondke Persson, et al. · American Journal of Physiology-Renal Physiology · 77
Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients
2015 · Hongbiao Lu, Jonas Busch, et al. · Clinica Chimica Acta · 67
Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy
2012 · Zofia Wotschofsky, Jonas Busch, et al. · Clinica Chimica Acta · 67
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
2021 · Sabine Kliesch, Stefanie Schmidt, et al. · Urologia Internationalis · 65
PDF
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
2022 · Katja Hönzke, Benedikt Obermayer, et al. · European Respiratory Journal · 63
PDF
Native T1 Mapping as an In Vivo Biomarker for the Identification of Higher-Grade Renal Cell Carcinoma: Correlation With Histopathological Findings
2018 · Lisa C. Adams, Bernhard Ralla, et al. · Investigative Radiology · 60
Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings
2019 · Lisa C. Adams, Philipp Jurmeister, et al. · European Radiology · 56
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma
2012 · Christoph Seidel, Jonas Busch, et al. · European Journal of Cancer · 54
Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma
2011 · Jonas Busch, Christoph Seidel, et al. · BMC Cancer · 54
PDF
Adult Tissue Extracellular Matrix Determines Tissue Specification of Human iPSC‐Derived Embryonic Stage Mesodermal Precursor Cells
2020 · Imran Ullah, Jonas Felix Busch, et al. · Advanced Science · 51
PDF
VEGF – Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC
2019 · Imran Ullah, Raed Abu-Dawud, et al. · Biomaterials · 51
Works count: 201
Citation count: 4,138
H-index: 36
I10-index: 77
Year
Topic
Type